Our quarterly public service, of providing an edited version of the Tesla earnings call, to remove the mumbles, bumbles and stumbles to make the podcast easier to listen to. Why? Because if he's ...

Java ranked third in the Tiobe Index for January 2026 at 8.71%, holding steady behind Python and C and just ahead of C++. Tiobe named C# its Programming Language of the Year for 2025 after the largest ...

Artificial intelligence and its promise to revolutionize programming—and possibly overthrow human sovereignty—is a central story of the post-Covid world. But for JavaScript developers, it is only one ...

TL;DR: PDF Agile gives Windows users a fast, full-featured PDF editor—complete with OCR, conversion tools, security features, and annotation—for a one-time $39.99 payment. If you spend any amount of ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

It’s a weird time to be a journalist. Digital news archives are disappearing. Generative AI is giving em dashes a bad name. Layoffs. Consolidations. Buyouts. Burnout. Countless, daily insults from the ...

This is read by an automated voice. Please report any issues or inconsistencies here. The Times obtained seven drafts of the LAFD’s after-action report on the Palisades fire. Deletions and revisions ...

The items were taken in the late 19th century from what was then called the Dutch East Indies. Indonesia had been trying to get them back for decades. By Nina Siegal Reporting from Amsterdam The ...

Enterprise Java platform Azul Systems Inc. today announced the acquisition of Payara Services Ltd., a global enterprise-grade provider of Java applications and microservices, to expand the company’s ...

Adobe’s tools can be launched directly inside a chat, simply by uploading a file and typing what you want done. You can say something like “Adobe Photoshop, help ...

For a decade after its discovery, CRISPR gene editing was stuck on the cusp of transforming medicine. Then, in 2023, scientists started using it on sickle-cell disease, and Victoria Gray, a patient ...